8-K
Current Report
Moleculin Biotech, Inc. Filed Acc 0001437749-23-024329
Bylaws or fiscal year change
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
From the SEC's structured data for this filing
Loading mbrx20230821_8k.htm…